Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (139)

2024

  1. Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Mpox, herpes, and enteroviruses: Differential diagnosis

    Journal of Medical Virology

2023

  1. Clinical outcomes by supplemental oxygen use in remdesivir-treated, hospitalised adults with COVID-19

    Infectious Diseases Now, Vol. 53, Núm. 7

  2. Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2

    Frontiers in Immunology, Vol. 14

  3. Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study

    The Lancet Microbe, Vol. 4, Núm. 1, pp. e21-e28

  4. Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

    Scientific Reports, Vol. 13, Núm. 1

  5. Plitidepsin in adult patients with COVID-19 requiring hospital admission: A long-term follow-up analysis

    Frontiers in Cellular and Infection Microbiology, Vol. 13

  6. Specific Cellular and Humoral Immune Responses to the Neoantigen RBD of SARS-CoV-2 in Patients with Primary and Secondary Immunodeficiency and Healthy Donors

    Biomedicines, Vol. 11, Núm. 4

  7. Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

    The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 11, pp. 2696-2701

  8. TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial

    Thorax, Vol. 78, Núm. 8, pp. 816-824

  9. Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e116-e125

  10. Use of Monoclonal Antibodies in Immunocompromised Patients Hospitalized with Severe COVID-19: A Retrospective Multicenter Cohort

    Journal of Clinical Medicine, Vol. 12, Núm. 3

2022

  1. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    International Journal of Clinical Practice, Vol. 2022

  2. Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir/Abacavir/Lamivudine in Antiretroviral-Naive Adults (SYMTRI): A Multicenter Randomized Open-Label Study (PReEC/RIS-57)

    Open Forum Infectious Diseases

  3. Discovering HIV related information by means of association rules and machine learning

    Scientific Reports, Vol. 12, Núm. 1

  4. Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial

    Trials, Vol. 23, Núm. 1

  5. Efficiency of screening for human immunodeficiency virus infection in emergency departments: a systematic review and meta-analysis

    Emergencias, Vol. 34, Núm. 3, pp. 204-212

  6. Epidemiologic and Economic Analysis of Rapid Antiretroviral Therapy Initiation with Bictegravir/Emtricitabine/Tenofovir Alafenamide in Spain

    PharmacoEconomics - Open, Vol. 6, Núm. 3, pp. 415-424

  7. Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019

    HIV Medicine, Vol. 23, Núm. 7, pp. 705-716

  8. Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19

    Life science alliance, Vol. 5, Núm. 4